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Summary 
We have analyzed the effect of antibodies (Abs) directed against major histocompatibility  complex 
(MHC) class II Abs on the proliferation of Theileria pan,a-infected  (Tpi) T  cells. Anti-MHC 
class II Abs exert a direct effect on Tpi T  cells causing an acute block in their proliferation. 
The inhibition does not involve apoptosis and is also entirely reversible. The rapid arrest of DNA 
synthesis caused by anti-MHC class II Abs is not due to interference with the state of activation 
of the T  cells since the transcriptional activator NF-rB remains activated in arrested  cells. In 
addition, interleukin 2 (IL-2), IL-2R, and c-m  F  gene expression are also unaffected. By analyzing 
the cell-cycle phase distribution of inhibited ceils, it could be shown that cells in all phases of 
the cell cycle are inhibited. The signal transduction pathway that results in inhibition was shown 
to  be  independent of protein kinase C  and  extracellular  Ca  2+.  Tyrosine kinase inhibitors, 
however, partly reduced the level of inhibition and, conversely, phosphatase inhibitors enhanced 
it.  The possible relevance of this phenomenon in other systems is discussed. 
T  cells that become infected with the protozoan parasite 
Theileria parva lose their dependence on antigen-specific 
priming and acquire the ability to proliferate  continuously 
in vitro. Like normal T cells, however, they remain depen- 
dent for their proliferation on the expression of the IL-2 and 
IL-2K genes (1, 2).  One significant  difference between T. 
pawa-infected (Tpi)  1 T cells and permanently transformed T 
cell lines is that the lymphoblastoid transformation caused 
by infection with the parasite is completely reversible. T cells 
return to a resting phenotype after elimination of the para- 
site using the parasite-specific drug BW720c (3). The way 
in which the parasite induces continuous proliferation is not 
entirely understood, but it has been shown in a number of 
Tpi cell lines that the continuous proliferation involves an 
IL-2/IL-2R-mediated autocrine loop that is strictly depen- 
dent on the presence of the parasite in the T cell cytoplasm. 
Cells from which the parasite has been eliminated by drug 
treatment can be maintained in culture for several more weeks, 
but only in the presence of exogenously added IL-2 and regular 
stimulation with phorbol esters. Because of the reversibility 
1 Abbreviations used in thispaper: CAT, chloramphenicol acetyl transferase; 
PI, propidium iodide; PKC, protein kinase C; Tpi, Thdlerla  pan,  a-infected. 
of their transformation, Tpi T cells provide an excellent model 
for the dissection of the various mechanisms that control T 
cell proliferation. In the present work, we examined the effects 
of anti-MHC class II Abs on the proliferation of Tpi T cells. 
Class II antigens of the MHC play a key role in immune 
responses and are best known for their role in antigen pre- 
sentation. However, additional, regulatory roles associated 
with monomorphic and polymorphic determinants of these 
molecules have recently been identified. It has been shown 
that MHC class II molecules expressed on lymphocytes are 
capable of transducing signals (4-10),  and there are several 
reports on the biological effects of anti-MHC class II Abs 
on monocytes (11, 12) and B cells (4, 5, 13-16).  In this re- 
gard, anti-MHC class II Abs have been shown to be potent 
inhibitors of B cell proliferation (10, 11, 14, 15). Activated 
T cells also express MHC class II molecules, but the biolog- 
ical consequences of the engagement by Abs of MHC class 
II molecules expressed on T cells is less clear than for B cells. 
Previous in vitro studies on T cells, stimulated to proliferate 
using anti-CD3 Abs in the presence of monocytes, have shown 
that the inhibition of T cell proliferation by anti-MHC class 
II Abs is predominantly effected indirectly through interfer- 
ence with the T cell activation pathway (12, 17-19).  Anti- 
MHC class II Abs were shown to exert  a direct effect on 
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expression by T cells was reduced significantly. A limited di- 
rect effect on T  cell proliferation could also be demonstrated 
(12). Mixed cultures of T  cells and monocytes, however, do 
not allow the indirect and direct effects of anti-MHC class 
II Abs on T  cells to be distinguished easily. Cell lines, con- 
sisting of continuously proliferating transformed cells such 
as lymphoma cells, are often used to address such problems. 
Permanently transformed cells of T cell lineage often possess 
altered genomes,  however, and in many cases lose growth 
factor dependence. For these reasons,  they may not always 
be representative of normal activated T cells. Tpi T cells fulfill 
this requirement more closely and, in this work, we describe 
how anti-MHC class II Abs can directly inhibit T cell prolifer- 
ation in a  reversible manner. 
Materials  and Methods 
Cells.  The characteristics  and maintenance of Tpi T cell clones 
have been described previously (20). The Tpi T cells used in this 
study were TpM(803) cells that are of the CD4 +CD8- phenotype 
and express the TCK-cx/B. Cells were cultured at 37~  in Dul- 
becco's L15 medium containing 20 mM Hepes (pH 7.1), benzyl- 
penicillin  (100 U/ml), streptomycin (100 #g/ml), t-glutamine (20 
#g/ml), 10% (vol/vol) heat-inactivated  fetal bovine serum (all from 
Gibco Laboratories,  Basel, Switzerland), and 50 #M 2-ME. Cell 
cultures were passaged every 2-3 d and their density was usually 
1-8  x  10Vml.  To eliminate the parasite  from the T  cells,  the 
theilericidal  drug BW720c (21) was added to the culture medium 
at a concentration of 50 ng/ml as described before (3). Recombi- 
nant I1.,2 used in a number of experiments was purchased from 
Amersham (Braunschweig, FRG; [ala125]interleuldn 2, code ARN. 
7010). 
Anti-MHC Class II Inhibition Experiments.  To test the antipro- 
liferative  activity  of anti-MHC  class II  Abs,  Tpi  T  cells  (104 
cells/well  in  200 #1) were cultured in medium containing 5% 
(vol/vol) of dialyzed anti-MHC class II hybridoma supernatant (cor- 
responding to 7.5 #g/mt of Ig; anti-HLA-DK; Code Nr. M704; 
Dakopatts, Hamburg, FKG) or the equivalent amount of control 
Ab. The anti-MHC class II Abs,  which bind to monomorphic 
regions of the bovine MHC class II molecules, and the control Abs 
(UPC 10, Code Nr. M-9144; Sigma, M~inich, FKG) were of the 
IgG2a isotype. Both Ab preparations were dialyzed extensively 
against Dulbecco's L15 medium which was used for the culture 
of Tpi T cells, and the FCS concentration was adjusted to that of 
the Tpi T cell culture medium (10% vol/vol). Preliminary experi- 
ments confirmed that inhibitory activity was contained in the pro- 
tein A-binding fraction and unspecific  toxicity of the hybridoma 
supernatant was excluded by testing it on a variety of different cell 
lines. Proliferation was monitored by measuring the incorporation 
of cells labeled for 2 h with 3.5 #Ci/ml of [methyl-3H]thymidine 
(code TRK.637; Amersham; 1 Ci  =  37 Gigabecquerel) (22). To 
test the effect of anti-MHC class II Abs on uninfected T cells, cul- 
tures were treated with BW720c for 4 d before addition of Ab. 
To ensure optimal growth, BW720c-treated cells were seeded at 
105 rather than l& cells/well. 
Band Shift and Transfection Analysis.  Tpi T cells were transfected 
with the plasmid construct  -121/232 HIV-CAT which contains 
two NF-gB binding sites that regulate its expression.  Details on 
the construct and transfection assays on Tpi T cells were reported 
before (23).  A  total of 5  x  l& cells were used per assay. After 
transfection, cells were cultured in normal medium or medium con- 
taining anti-MHC class II or control Abs. Lysates were prepared 
after 24 and 48 h and tested for chloramphenicol acetyl transferase 
(CAT) activity. The preparation of nuclear extracts and gel retarda- 
tion analysis were performed as described previously (24); 5  x  106 
cells were used per assay. The oligonucleotide used for gel retarda- 
tion assays contains the NF-KB binding sequence motif which is 
also present in the HIV-LTK. 
Northern BlotandPCR Analysis.  The Tpi T cells were cultured 
in 25 cm  2 flasks in the absence or presence of anti-MHC class II 
Abs. Northern blot analysis of polyadenylated RNA using the bo- 
vine IL-2K/Tac and actin cDNA probes was performed as described 
before (20,  22,  25).  The bovine c-myc probe originates from a 
genomic clone and contains exon 1- and exon 2-specific sequences 
(Dobbelaere, D.A.E., unpublished results). Control B cell mKNA 
was prepared from the bovine B cell line B155 (donated by Dr. 
L. Droogmans, Universit6 Libre de Bruxelles, Brussels, Belgium). 
PCK analysis of Ib2 gene transcription using Ib2-specific primers 
was performed as described (1). Control PCR using actin-specific 
primers confirmed the quality of the KNA and cDNA synthesis 
of the various  KNA preparations (data  not shown). 
Cell Cycle Analysis.  Tpi T cells were cultured in 96-well plates 
in 200 #1 of medium containing either control or anti-MHC class 
II Ab. At the times indicated, cells were harvested from pools of 
wells and briefly trypsinized to disperse clumps. To avoid extensive 
cell lysis during ethanol fixation, cells were fixed (0~  30 min) 
in 1% paraformaldehyde/0.5%  saponin in PBS, washed, and blocked 
with 0.1 M glycine/0.1 M phosphate, pH 7.4. Cells were stored 
at 4~  until analysis. Aliquots of 2.5  x  1@ cells were resuspended 
in 30 #1 of PBS containing 100 #g/m1 propidium iodide (PI), 250 
#g/ml RNase A and 0.5% saponin, and incubated for 30 min at 
37~  270 #1 100 #g/ml PI in PBS were added and cells stored 
in darkness  at 4~  for at least 6 h before analysis. Measurements 
were made on a FACStar Plus|  30 system (Becton Dick- 
inson, Heidelberg, FKG) using PBS sheath fluid and 150 mW of 
excitation light at 488 nM.  Red (PI) fluorescence  was coUected 
through a DF630/38 filter. List mode data was processed with the 
Cellfit program (Becton Dickinson) using computer gating  on 
fluorescence pulse area, height, and width to generate histograms 
only of intact single cells with an apparent DNA content between 
2 and 4 times the haploid complement. These were analyzed by 
the software's sum of broadened rectangles (SOBK) model to give 
a goodness-of-fit  (X  2) of between 1.06 and 1.40 in the experiment 
shown. 
Tyrosine Kinase and Phosphate Inhibitor Studies.  Before the addi- 
tion of Abs to the culture medium, cells were cultured overnight 
in the presence of either 1 #M herbimycin A, 1 #g/ml genistein 
(both from Calbiochem, Bad Soden, FKG) or 15 #M sodium or- 
thovanadate (Sigma). Cells were then washed twice in medium and 
cultured (104 cells/well in 200 #1) in the presence  or absence of 
anti-MHC class II Abs in normal medium or medium containing 
one of the following inhibitors: herbimycin A (1 #M), genistein 
(10 #g/ml), or sodium orthovanadate (15 #M). The percent inhi- 
bition induced by treatment with anti-MHC class II Abs obtained 
for cells grown in the presence or absence of the inhibitor were 
then compared and are presented (see Fig.  4). 
Results 
Anti-MHC  Class II Abs Cause the Rapid Arrest  of Tpi T 
Cell Proliferation.  Like activated T calls of most species, Tpi 
T cells express MHC class II molecules on their surface (20). 
When  anti-MHC  class  II Abs  were added  to  the  culture 
medium of Tpi T  cells a rapid  arrest of their proliferation 
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MHC class II Abs. (,4) Tiff  T cells  were  cultured  in the pres- 
ence of control or anti-MHC class II Abs and their DNA 
synthesis was monitored  by measuring  [3H|TdR incorpora- 
tion after 2, 4, 6, or 24 h of culture. (B) Inhibition  by anti- 
MHC class II Abs is reversible. Tiff  T cells were  cultured  for 
24 h in the presence  of anti-MHC  class II Abs, then washed 
with medium  to remove  the Abs and cultured  for an addi- 
tional 24 h. [3H]TdR incorporation  was measured after 24 
and 48 h. (C and D) The addition  of rlL-2 does not restore 
the proliferation  of cells arrested by anti-MHC class II Abs. 
Tiff T cells (C) or T cells cured of the parasite by treatment 
for 4 d with BW720c (D) were cultured for 24 h in normal 
culture medium  or medium  containing  control  or anti-MHC 
class II Abs, in the absence or presence of 10 U/ml of rlL-2. 
laH]TdR incorporation  was measured  after 24 h. (.4 and B) 
Data are presented  as the percent  incorporation  measured  for 
Tpi T cells cultured  in the presence of control Abs. (C and 
D) Data are presented as cpm x  10 -3 per 104 cells seeded. 
Error bars represent 1  SD of the mean  of  values  from  quadru- 
plicate cultures. 
could be observed. Fig. 1 A  shows an experiment in which 
DNA synthesis of Tpi T  cells, measured by [3H]TdR incor- 
poration, was reduced to <50% within 4 h and >90% inhi- 
bition was reached by 24 h. The inhibition at 24 h observed 
in most experiments could range from 70 to >95%. Inhibi- 
tion did not result from apoptosis, since DNA fragmenta- 
tion or changes in cell viability could not be observed.  In 
addition, the inhibition proved to be reversible, since DNA 
synthesis resumed upon removal of the Abs from the culture 
medium, and cells achieved a proliferation rate comparable 
with that of control cultures within 24  h  (Fig.  1 B). 
It has been shown that the inhibition of anti-CD3-stimu- 
lated T cells by Abs directed against MHC class II molecules 
in the presence of monocytes (12) could be abrogated by the 
addition of IL-2 to the culture medium. In contrast to these 
observations, the addition of rlL-2 to the culture medium 
of Tpi T  cells inhibited by anti-MHC class II could not re- 
store proliferation (Fig.  1 C). Inhibition was not restricted 
to this particular CD4+CD8 -  Tpi T  cell line since other, 
CD4-CD8 +  and  CD4-CD8-  Tpi  T  cells  were  also  in- 
hibited (data not shown). Inhibition was also not dependent 
on the T cells being infected with T.parva, since T cell clones 
that were cured of the parasite,  but cultured under condi- 
tions which allow them to continue to proliferate (3) were 
also inhibited. Furthermore, the addition of rlL-2 again failed 
to abrogate the inhibition of proliferation mediated by the 
anti-MHC class II Abs  (Fig.  1 D). 
The Activation of the ~ansc@tion Factor NF-KB Is Not In- 
hibited.  One of the typical features of early T cell activation 
is the activation of the transcription factor NF-KB which is 
involved in the regulation of IL-2 (26) and IL-2R gene ex- 
pression (27).  In Tpi T  cells,  NF-KB can also be found in 
the activated form in the nucleus (23). Since it had been pro- 
posed that anti-MHC class II Abs cause the downregulation 
of T cell activation and consequently of IL-2 and IL-2R ex- 
pression (12, 17,  18), we examined the effect of these Abs 
on the activation of NF-KB. Band shift analysis using nuclear 
extracts from control Tpi T  cells or cells treated with anti- 
MHC class II Abs revealed no difference in the level of NF- 
rB activity (Fig. 2 A). To test if NF-rB was also biologically 
functional, Tpi T cells treated with anti-MHC class II were 
transfected with the plasmid HIV-CAT in which CAT gene 
expression is controlled by the two NF-KB binding sequences 
contained in the HIV LTR. No difference in CAT activity 
could be observed  when cells treated with anti-MHC class 
II were compared with control cells (Fig.  2 B). 
Anti-MHC Class II Abs Do Not Inhibit IL-2,  IL-2R, and 
c-myc Expression.  It has been reported for T cells stimulated 
to proliferate by anti-CD3 Abs in the presence of monocytes, 
that the addition of anti-MHC class II Abs to the culture 
medium results in a reduction of IL-2R and IL-2 expression 
(18). Northern blot analysis showed that treatment of Tpi 
T  cells with anti-MHC class II Abs did not inhibit IL-2R 
ol chain (p55) mRNA expression, which is normally induced 
upon T cell activation and also in Tpi T cells (Fig. 3 A). Like- 
wise, the expression  of the proto-oncogene c-myc, normally 
induced upon T  cell activation, was not inhibited. Analysis 
by PCR (Fig.  3 B) revealed that IL-2 mRNA expression  is 
also not inhibited by anti-MHC class II Abs, whereas, in a 
control experiment, elimination of the parasite by addition 
of the theilericidal drug BW720c clearly resulted in the dis- 
appearance  of IL-2 mRNA. 
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class II-treated Tpi T cells. (A) Gel retardation analysis with 32P-labeled 
NF-xB-binding  oligonucleotides.  Binding assays  were performed  using nu- 
clear extracts prepared from control Tpi T cells or Tpi T cells cultured 
for 24 h in the presence  of anti-MHC class II or control Abs. (B) Demon- 
stration of NF-KB  activity  by HIV-CAT  transfection  assay. Tpi T cells  were 
transfected with the plasmid construct (-121/232) HIV-CAT  which de- 
pends on the presence  of activated NF-KB for its expression. After trans- 
fection, cells  were cultured in normal medium or medium containing anti- 
MHC class II or control Abs. Lysates  were prepared after 24 and 48 h 
and tested for CAT activity. 
These data and the experiments carried out on the activa- 
tion of NF-KB strongly suggest that the inhibition of prolifer- 
ating  Tpi T  cells by anti-MHC  class  II Abs  is  not  due  to 
an inhibition  of the  IL-2/IL-2R  activation  pathway. 
Cells Are Inhibited in All Stages of the Cell Cycle.  Experi- 
ments were also carried out to determine in which phase of 
the cell cycle cells are arrested after treatment with anti-MHC 
class II Abs.  Cells  were incubated with anti-MHC  class  II 
Abs or control Abs  and  at different times,  ranging from 3 
to  50 h  after Ab  addition,  proliferation was  monitored by 
measuring  [3H]TdIL incorporation.  Cell-cycle distributions 
were analyzed in parallel by carrying out PI staining of the 
DNA followed by flow cytometry. Surprisingly, no substan- 
tial cell-cycle phase differences could be detected between ar- 
rested  cells  and  control  cells,  even  in  experiments  where 
[3H]TdR incorporation was inhibited up to 99%.  A  repre- 
sentative experiment is shown in Table 1. These results indi- 
cate that cells that are inhibited in their proliferation by anti- 
class II Abs do not gather in a defined stage of the cell cycle, 
but,  instead,  are  arrested in  all  stages  of the  cell cycle. 
Anti-MHC Class  II-mediated Inhibition Is Independent  of  Protein 
Kinase C (PKC) and Extracellular Ca  e+, but Involves Tyrosine 
Phorphorylation.  MHC class II-mediated signals have been 
shown to result in the mobilization of Ca  2+ , changes in the 
protein tyrosine phosphorylation patterns (3, 6), and the ac- 
tivation of serine/threonine-specific PKC (7). One of the con- 
sequences of ligand engagement of MHC class II molecules 
is the expression of lymphocyte adhesion molecules, resulting 
in pronounced lymphocyte aggregation (28). It has been shown 
that the induction of adhesion involves the activation of PKC 
Figare  3.  IL-2R/Tac,  c-myc,  and Ib2 mRNA expression  in Tpi T cells 
treated with anti-MHC class II Abs. (A) Northern blot analysis of IL- 
2R/Tac and c-myc  mRNA expression  in Tpi T cells cultured in the pres- 
ence or absence of anti-MHC class II Abs. Filters were rehybridized  with 
a bovine cDNA actin probe as a control for the amount of RNA loaded. 
(/3) PCR analysis of IL-2 mRNA expression  in Tpi T cells cultured in the 
presence of control Abs, anti-MHC class II Abs, or in culture medium 
without additives. A control PCR demonstrating the disappearance of 
IL-2 mtLNA transcripts upon elimination of the parasite was performed 
on mRNA isolated  from cells  cultured for 3 d in the presence  of the theileri- 
cidal drug BW720c. Polyadenylated  tLNA isolated from a bovine B cell 
line was used as an additional negative control. 
and is sensitive to inhibitors of PKC (16). Treatment of Tpi 
T  cells with anti-MHC  class II Abs also induced extensive 
aggregation of Tpi T  cells that could be inhibited by the PKC 
inhibitor H7 and the chelating agent EGTA. The inhibition 
of DNA synthesis caused by treatment with anti-class II Abs, 
however, was not affected by either reagent (data not shown). 
Treatment  of the  cells with  the  tyrosine kinase  inhibitors 
genistein  and  herbimycin  A,  on  the  other  hand,  partly 
abrogated the inhibition, whereas the phosphatase inhibitor 
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Percent cells in 
Percent [3H]TdR 
Time  Antibody  G1  S  G2  +  M  incorporation (+  SD) 
h 
0 
24 
50 
None  27.6  58.8  13.6  ND 
Control Ab  29.6  56.5  13.9  100.0 (_+  8.0) 
Anti-class [I  28.4  58.0  13.6  28.5 (_+  1.5) 
Control Ab  27.5  62.7  9.8  100.0 (+  15.0) 
Anti-class II  29.8  59.8  11.5  0.9 (_+  0.1) 
Tpi T cells were cultured in normal medium in the presence or absence of control or anti-MHC class II Abs. At the times indicated, cells were 
harvested, fixed  in 1% paraformaldehyde/0.5%  saponin and DNA staining  carried out with Pl. Cells were then analyzed  on the FACS  |  for relative 
DNA content. [3H]TdR incorporation  was measured  in parallel and is expressed as a percentage of the value obtained for cells treated with control Ab. 
sodium orthovanadate was capable of enhancing the inhibi- 
tory effects caused by anti-MHC class II treatment (Fig. 4) 
suggesting the involvement of tyrosine kinase activity in the 
signal cascade resulting in the arrest of proliferation. 
Discussion 
In the present paper, we show that the engagement of MHC 
class II molecules, which are expressed  on Tpi T  cells, can 
result directly in the inhibition of their growth. This nega- 
tive regulation is unusual in that it involves  a rapid arrest 
of DNA synthesis upon treatment with anti-MHC class II 
Abs, without affecting the state of activation of the T cell, 
as measured by NF-rB activity and IL-2 and IL2-R gene ex- 
pression.  In addition, the inhibition does not involve apop- 
tosis and is totally reversible. 
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Figure 4.  The effect  of phosphatase and tyrosine  kinase  inhibitors on 
anti-MHC class II-mediated  inhibition  of Tpi T cells. Cells were first cul- 
tured overnight  in the presence of the various inhibitors  and then plated 
out and cultured for a further 24 h in medium  containing  the inhibitors 
in the presence or absence of anti-MHC class II Abs. Proliferation  was 
monitored by measuring  [3H]TdR incorporation. (B/ack  Mrs) Control  cul- 
tures. (Open and gray bars) Percent proliferation  compared with control 
cultures for cells treated with anti-MHC class II Abs in the absence or 
presence of the inhibitor. 
Our observations differ substantially from earlier  work 
describing the inhibitory effect of anti-MHC class II Abs on 
T cells stimulated to proliferate by anti-CD3 Abs in the pres- 
ence of monocytes (12, 18,  19), or in MLCs (17). In these 
previous studies it was shown that the monocytes are the 
main target of inhibition and that the arrest of T cell prolifer- 
ation occurred through blocking their activation. Inhibition 
was due to interference with cell-cell interactions between 
macrophages and T cells at the early phases of activation (12, 
19), and negative effects on IL-I~/and IL-6 mRNA expres- 
sion were also reported (18). In the same studies, IL-2 and 
IL-21L expression in the affected T cells were also clearly re- 
duced. In Tpi cells arrested  by anti-MHC class II Abs,  no 
decrease in IL-2, IL-2R, and c-myc mRNA expression could 
be detected, and the transcriptional activator NF-rB, which 
is involved in the regulation of the IL-2 and IL-2R genes, 
also remains activated. Therefore, whereas in mixed cultures, 
monocyte-dependent  T cell activation and subsequent IL-2/IL- 
2R-mediated proliferation of T cells may be inhibited by anti- 
MHC class II Abs, our data clearly show that there also exists 
a direct way by which anti-MHC class II Abs can inhibit 
T cell proliferation which does not involve the T cell activa- 
tion signal pathway. Indeed, it would be difficult to imagine 
how the inhibition of the signal pathway that results in IL-2 
and IL-2R gene expression  could result in such rapid arrest 
of proliferation, especially considering the fact both genes 
are already expressed  at the time Tpi T  cells are exposed to 
the Abs. 
The nature of the inhibitory pathway is still poorly under- 
stood. In other systems, Ab binding to MHC class II mole- 
cules has been shown to cause changes in [Ca2+]i and also 
altered serine/threonine-specific PKC (10) and protein tyro- 
sine kinase activity (6, 9). In agreement with these previous 
studies, we could show that the PKC inhibitor H7 and the 
calcium chelator EGTA prevented anti-MHC class II-medi- 
ated aggregation of Tpi T  cells. These inhibitors, however, 
did not prevent the arrest of DNA synthesis. The tyrosine 
kinase inhibitors herbimycin A and genistein, on the other 
hand, partly abrogated inhibition, whereas the phosphatase 
773  Eichhorn  et al. inhibitor sodium orthovanadate enhanced inhibition. These 
preliminary data suggest that at least two separate signaling 
pathways are triggered by MHC class II engagement: a PKC- 
dependent pathway that results in aggregation, and a pathway 
involving tyrosine kinase activity that can result in the arrest 
of DNA synthesis. In this regard, our observations resemble 
those for the anti-IgM-mediated inhibition of a human B 
cell lymphoma which was also shown to be independent of 
PKC activation and involved tyrosine phosphorylation (29). 
In this case, herbimycin A and genistein also reversed anti- 
IgM-induced inhibition of growth. The signaling resulting 
from MHC class II engagement is complex and there is evi- 
dence that the participation of other surface molecules may 
determine whether MHC class II engagement will enhance 
or inhibit proliferation. This way, it was shown by one group 
that the anti-MHC class II mAbs Q5/6 and Q5/13 could 
enhance T  cell proliferation induced via the CD2 molecule 
(30),  whereas in another report, T  cells treated with anti- 
CD3 Abs were inhibited by the same anti-MHC class II Abs 
(12, 19). A recent report (31), however, also showed that anti- 
MHC class II Abs could synergize with submitogenic amounts 
of anti-CD3 mAb in causing proliferation and lymphokine 
secretion. Such opposite activities have also been demonstrated 
for Abs that bind to other lymphocyte surface ligands (32-34). 
The fact that cells inhibited by anti-MHC dass II Abs are 
arrested in all phases  of the cell cycle is puzzling, but not 
without precedent since non-phase-specific cell cycle arrest 
is also induced by anti-MHC class II Abs in B cells (11). The 
mechanism by which this is achieved is up till now entirely 
unknown, but MHC class II-mediated inhibition of Tpi T 
and also B cell proliferation (11) dearly differs from the irre- 
versible arrest in G1-S induced by anti-CD3 and anti-Thy-1 
Abs (33). 
The fact that T cells that were cured of the parasite were 
also inhibited would indicate that anti-MHC class II-medi- 
ated inhibition of proliferation is not restricted to T cell clones 
that harbor T parva.  Although we do not want to gener- 
alize, the notion that Abs directed against MHC class II mol- 
ecules can directly inhibit the proliferation of activated T cells 
is of considerable relevance, in particular, since such Abs can 
be detected in patients with autoimmune disease such as SLE 
and rheumatoid arthritis (35, 36).  In this regard, we have 
found in preliminary experiments that sera from several pa- 
tients with SLE potently inhibited the proliferation of Tpi 
T cells (Eichhorn, M., and D. A. E. Dobbelaere, unpublished 
observations). In addition, evidence exists that Abs reactive 
with MHC class II antigens are generated in patients infected 
with HIV, apparently owing to amino acid sequence similar- 
ities between MHC class II and certain HIV-derived pep- 
tides (37-39). This has led to the proposal that autoimmune 
responses against HLA MHC class II molecules could lead 
to the progressive deterioration of the immune system. In 
the latter context, it has been shown that certain HIV enve- 
lope proteins are capable of activating T  cells (40).  An in- 
triguing corollary of the fact that these HIV peptides can 
induce T cell activation, and thus MHC class II expression, 
is that this could predispose such cells to the inhibitory effects 
of the anti-MHC class II Abs. 
Further work will be required,  however, to  determine 
whether inhibitory mechanisms similar to the one described 
in this paper are also involved in the pathogenesis of autoim- 
mune diseases and AIDS. 
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